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Abstract
Background: Staphylococcus aureus secretes numerous exotoxins which may exhibit superantigenic properties. Whereas
the virulence of several of them is well documented, their exact biological effects are not fully understood. Exotoxins may
influence the immune and inflammatory state of various organs, including the sinonasal mucosa: their possible involvement
in chronic rhinosinusitis has been suggested and is one of the main trends in current research. The aim of this study was to
investigate whether the presence of any of the 22 currently known staphylococcal exotoxin genes could be correlated with
chronic rhinosinusitis.
Methodology/Principal Findings: We conducted a prospective, multi-centred European study, analysing 93 Staphylococcus
aureus positive swabs taken from the middle meatus of patients suffering from chronic rhinosinusitis, with or without nasal
polyposis, and controls. Strains were systematically tested for the presence of the 22 currently known exotoxin genes and
genotyped according to their agr groups. No direct correlation was observed between chronic rhinosinusitis, with or
without nasal polyposis, and either agr groups or the presence of the most studied exotoxins genes (egc, sea, seb, pvl,
exfoliatins or tsst-1). However, genes for enterotoxins P and Q were frequently observed in nasal polyposis for the first time,
but absent in the control group. The number of exotoxin genes detected was not statistically different among the 3 patient
groups.
Conclusions/Significance: Unlike many previous studies have been suggesting, we did not find any evident correlation
between staphylococcal exotoxin genes and the presence or severity of chronic rhinosinusitis with or without nasal
polyposis.
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Introduction
Chronic rhinosinusitis (CRS) is an inflammation of the upper
airway mucosa and is often associated with asthma. The
prevalence of CRS is about 16% of the general population in
western countries [1]. It is associated with a significant reduction of
patients’ quality of life and high economic costs [1].
A comprehensive definition of CRS was described in the recent
EPOSarticle[1]:CRSis aninflammationofthenoseandparanasal
sinus mucosa, characterised by persistent symptoms for over 12
weeks. There must also be signs on nasal endoscopy and/ or CT-
scan. The development of nasal polyposis (CRSwNP) can be an
additional clinical finding in approximately 20% of CRS cases and
is considered to be the ultimate development of the disease [1,2].
The pathophysiology of CRS is not fully understood and is most
likely multifactorial. Systemic host factors, including genetic
background [3,4], host immunological profile and environmental
factors are thought to predispose to the development of CRS [2].
According to several recent studies, bacterial colonization and,
especially bacterial products such as exotoxins from Staphylococ-
cus aureus (SA), could be implicated in the pathogenesis of CRS
with or without NP [5–8].
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with several lethal human infections [9–11]. Exotoxins from SA
are exported to the extracellular space, where they can act as
superantigens. Some of these exotoxins have been identified as
important contributors in food intoxications [9–12] and were thus
called enterotoxins. Others have been found to be potential
markers of severe infections [13,14]. They play a role not only in
classical staphylococcal infections, but also during non-infectious
diseases [15]. Most SA exotoxins (SE) are pore-forming molecules:
the exfoliatins are responsible for the necrotising skin rash in the
newborn [9]; the toxic-shock staphylococcal toxin (TSST-1) is
known to induce shock in the menstrual toxic-shock syndrome
[9–11]; the Panton-Valentine leukocidin (PVL) is responsible for
necrotizing haemorrhagic pneumonia, skin and osteoarticular
infectious manifestations [16–18]. However, 80% of healthy
subjects show the presence of anti-TSST-1 antibodies in their
plasma; in contrast, similar antibodies are found in only 20% of
patients showing toxin-related septic shock [19].
Staphylococcal exotoxins can act as superantigens, which are
able to directly stimulate T cells, thus producing an intense
polyclonal immune response. SE can bind to the side of T cell
MHC-II V beta domains receptors [20], inducing a potent
immune response without the need of antigen-specific recognition.
Recent studies suggest that certain SE (enterotoxins A, B, C, D
and TSST-1) may act as superantigens in the pathogenesis of
CRSwNP, worsening inflammation by inducing an immunological
response [5–8,21]. A normal humoral immune response might
also participate by adding antigen-antibody stimulated inflamma-
tion [5]. The severity of CRSwNP could be associated with an
immunological response toward exotoxins released by SA
colonizing the nose [5–8,21]. This hypothesis was supported by
the absence of exotoxins in non-polypoid mucosa from 11 patients,
screened for staphylococcal enterotoxins A, B, C, D & TSST-1
[8].
A possible involvement of different SE in nasal mucosal
inflammation has been proposed. Our study was designed to
investigate whether a correlation between the presence of SA
exotoxin genes (se) and CRS could be observed. Hence, we
designed a prospective, multi-centred European study, to mini-
mize bias due to local SA epidemiology. As previous reports have
shown the frequent association of CRSwNP, asthma and non-
steroid anti-inflammatory drugs (NSAID) intolerance (known as
Widal-Lermoyez syndrome [22] or Samter’s Triad [23]), we also
collected data on the presence of these conditions in all patients.
Methods
Inclusion criteria were a positive middle meatus swab for SA in
patients undergoing nasal endoscopic surgery during the study
period. Exclusion criteria were based on a positive medical history
of allergy, current upper respiratory tract infection and systemic
corticotherapy during the last 6 months. All CRS patients, with or
without polyps, were under topical corticotherapy for more than
six months.
Among 268 patients, 214 were recruited because they were
suffering from CRS, with or without NP; 54 patients were
recruited as controls, according to the criteria listed below. 93
patients out of the 268 were positive for intranasal SA carriage and
were therefore included in the study: 71 suffering from CRS and
22 controls. Ages ranged between 16 and 82 years, encompassing
39 females and 54 males, recruited in Paris (France) (n=27),
Bruges (Belgium) (n=9), London (UK) (n=2), Zagreb (Croatia)
(n=6) and Geneva (Switzerland) (n=49: 27 CRS and 22 SA
healthy carriers as controls).
The patients were divided into three groups. The first group was
composed of 55 patients suffering from CRSwNP, the second
group contained 16 patients suffering from CRS without NP
(CRSsNP) and the third group consisted of 22 controls, from. All
patients in the first two groups were diagnosed with CRS
according to the EPOS definition [1]. All patients in the control
group underwent nasal endoscopic surgery for non-CRS related
conditions. Nasal polyposis severity was evaluated by endoscopic
examination, following the Malm classification (stage 1=polyps
present in the middle meatus; stage 2=polyps extending below the
middle turbinate; stage 3=polyps reaching the floor of the nasal
cavity) [24]. A history of asthma (categorised into moderate or
severe) and Widal syndrome was noted.
Bacteriological samples were obtained from all patients by
swabbing the middle meatus mucosa under endoscopic control. A
Gram stain was performed and the quantity of SA bacteria (QB)
was categorised into 3 groups: ‘‘low’’ was defined by the presence
of colonies only in the first streaking quadrant on a Petri dish,
‘‘moderate’’ when colonies were present in the first two streaking
quadrants and ‘‘abundant’’ whenever colonies were found in the
third streaking quadrant.
Identification of SA was performed according to CLSI
recommendations [25]. Each sample was tested for the presence
of the femA gene, a SA-specific gene in order to confirm species
identification and to assess the quality of further PCR amplifica-
tions. PCR was also used to detect the presence of the 22 currently
known SA exotoxins genes and 2 pseudogenes. These determina-
tions included PVL, TSST-1 and exfoliatins A and B genes, as well
as 18 enterotoxin genes (se). The 2 non-functional pseudogenes,
yent1 and yent2, can rearrange together to yield the functional
enterotoxin gene seu [26]. Their presence was not considered in
the final analysis; rather, we only considered the presence of the
functional gene. Because they usually co-transfer between bacteria,
seg, sei, sem, sen, seo seu form a cluster named egc (enterotoxin gene
cluster). Likewise, sed and sej usually co-transfer and, so, form
another cluster.
We analysed the data to investigate a possible correlation
between the presence and severity of CRS and the presence and
quantity of both bacteria and se.
DNA Preparation
Genomic DNA was extracted using Dneasy kit (QIAGEN,
Hilden, Germany) from isolated colonies freshly grown on Mueller
Hinton agar plates (Difco). Each strain was suspended in 500 ml
Tris-EDTA buffer (TE, 10mM Tris and 1 mM EDTA), then
washed twice by centrifugation for 10 minutes at 4000 g. The
pellet was suspended in 200 ml TE supplemented by 100 mgo f
lysostaphin (Ambicin, Applied Microbiology, Tarrytown, NY), and
incubated for 10 minutes at 37uC. DNeasy spin columns were then
used following manufacturer’s recommendations. DNA concen-
tration and purity were assessed by using NanoDrop ND-1000
spectrophotometer (NanoDrop Technologies, Inc., Rockland,
DE). For clinical isolates tests, fast DNA extraction was performed
using glass beads (in Tris-EDTA buffer) and vortex agitation [26].
5 ml of crude lysate were used to performed PCR amplifications.
Control experiments showed that rapid extraction yielded similar
results to purified DNA samples [26].
Primers and PCR Amplification
SA genotyping was performed according to accessory gene
regulator (agr) groups, using a previously published real-time
multiplex PCR assay [27]. This consists of a quadruplex PCR
amplification allowing discrimination of the 4 different alleles
which define the agr groups of SA [28]. Enterotoxins were
Enterotoxins in Rhinosinusitis
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each PCR mixture was loaded in a BioAnalyzer 2100 device using
DNA 1000 chip, yielding to an outstanding resolution from 25-
1000 bp. Results were analyzed using specific software previously
described in the study of SA by VNTR [30]. Briefly, BioAnalyzer
output files containing raw fluorescence data were exported and
processed to discriminate peaks from background signals.
Exfoliatin A and B genes (etA and etB), tsst and pvl were identified
as formerly described [27].
Rapid genotyping was performed using a recently published
multilocus variable number of tandem repeats assay (MLVA) using
10 primer pairs [30,31] and a microcapillary electrophoresis
system for the rapid evaluation of the MLVA profile. MLVA
genotyping is a rapid methodology allowing the identification of
the bacterial genetic background and the relatedness between
isolates with a discrimination power at least comparable to that of
PFGE [30].
Statistical Analysis
The ‘‘Fisher Exact Test’’ was used to calculate the P-values
reflecting the difference between groups containing categorical
data. The ‘‘Mann Whitney U Test’’ was used for the same purpose
with quantitative data and a chi-squared test for 3 comparison
groups. A p-value inferior to 0.05 was considered as significant.
Ethic Statement
This study was approved by the Geneva University Hospital
Ethics Committee. Informed consent was obtained: written in
Geneva and Paris and verbal in London, Bruges and Zagreb. All
patients were informed that their swab results and clinical findings
would be kept anonymous. The data transmitted to the last author
concerned the state of CRS and grade of polyposis, the bacterial
load, the grade of asthma and any non steroid anti-inflammatory
drugs intolerance.
Results
The presence of SA was documented by culture in 71/214
(33.2%) patients suffering from CRS, among whom 55 CRSwNP
and 16 CRSsNP, and in 22/54 controls (40.7%): these rates are
similar to the SA intranasal carriage in the general population [13]
as previously described by our group [32,33]. The proportions of
SA intranasal carriers in the CRS group were of 44.3% in Paris
(n=27/61 CRS), 32.1% in Bruges (n=9/28 CRS), 50% in
London (n=2/4 CRS), 18.2% in Zagreb (n=6/33 CRS) and
30.6% in Geneva (n=27/88 CRS). 175/214 patients were
negative for SA intranasal carriage, among whom 143 CRS
patients, 91 CRSwNP and 52 CRSsNP, and 32 controls.
Among the 214 CRS patients with and without polyps, 71 were
intranasal Staphylococcus aureus carriers and 143 were non-carriers;
in the control group, 22 were intranasal SA carriers and 32 non-
carriers: no significant difference was found between those groups
(p-value=0.188 - Fisher Exact Test). We also analyzed the
subgroups separately, following their clinical status (CRSwNP,
CRSsNP) and controls. Within the CRSwNP patients group, 55
were intranasal SA carriers and 91 non-carriers; within the
CRSsNP patients group, 16 were intranasal SA carriers and 52
non-carriers. There was no significant difference between those 3
groups either (p-value=0.075 - Chi-Squared Test).
Regarding the SA intranasal carriers, accessory gene regulator
(agr) typing showed a similar distribution of each of the 4 alleles in
all patients studied. The most abundant agr-type identified overall
was type I, irrespective of the geographical origin of the SA strains.
Rapid genotyping failed to identify clusters matching the
geographical origin of the isolates (cf. figure 1). Thus, considering
the three populations subjected to MLVA analysis, we observed a
large diversity of unrelated isolates, derived from various genetic
backgrounds, with the largest clusters containing a maximum of 3
strains, without correlation with any group of patients.
Each of the 3 patient groups contained SA strains with and
without se. The distribution across the patient groups is illustrated
in figure 2. The quantity of each se found in each group and
subgroup is displayed in Table 1. At least one se was detected in
79/93 patients (84.9%), including 46/55 with CRSwNP (83.6%),
15/16 with CRSsNP (93.7%) and 18/22 controls (81.2%)
(Table1). There was no statistically significant difference between
these rates in CRSwNP patients and controls (p=0.253),
CRSwNP and CRSsNP patients (p=0.22) or the CRSsNP
patients and controls (p=0.233). A more detailed analysis of the
CRSwNP group was performed by dividing it into 3 subgroups,
according to the stage of nasal polyposis (stage 1=NP1, stage
2=NP2, stage 3=NP3). At least one se was detected in 24/25
patients with NP1 (96%), 20/24 with NP2 (83%) and only 2/6
with NP3 (33%). There was no statistically significant difference in
rates between groups NP1 and NP2 (p=0.15). NP3 was too small
to be analyzed.
There was no geographical difference in the carriage of any
particular se. The different types of se were equally distributed
between women and men. Figure 3 shows the percentages of each
gene detected in the three groups. No individual se was always
present in all of the 79 patients in which se were detected. The
most frequently detected se were those of the egc (enterotoxin gene
cluster: seg, sem, sen, sei, seo, seu), in 75/79 patients (94.9%). All
patients in the CRS and control groups who had se detected had
the egc present, while the only four patients without genes of this
cluster (but with other se present) were in the CRSwNP group.
Other commonly detected se were tsst-1 (19/79; 24%), sea, sec, sel
(14/79; 17.7%), sep, seh (10/79; 12.7%) and seq (9/79; 11.4%). see,
sek and etB were not detected in any patient. All other exotoxins
were detected in only 1 or 2 patients (Table 1).
The detection rates of each se in the CRSwNP and control
groups were compared by the Fisher exact test. Statistically
significant differences were found for sep (p=0.039) and seq
(p=0.033), both of which were present in 8 and 9 CRSwNP
patients, respectively, but not found in any control patient. There
was no difference in the detection rates of any other se between
these groups (Table 1).
Overall, there were 318 se detected in the 55 patients with
CRSwNP, 85 detected in the 16 patients with CRSsNP and 125
detected in the 22 controls. Using the Mann Whitney U Test,
there was no statistically significant difference between the overall
numbers of se detected in the CRSwNP and control groups
(p=0.532), the CRSwNP and CRSsNP groups (p=0.259) and the
CRSsNP and control groups (p=0.492) (Table 2). The median
number of se per patient was 7 in the CRSwNP group (range 0–
11), 6.5 in the CRS group (range 0–8) and 6 in the controls (range
0–8). Hence, no SA strain carried all of the 22 known se.
The CRSwNP group revealed 161 se detected in the 25 NP1
patients, 144 in the 24 NP2 patients and 13 in the 6 NP3 patients,
with no significant difference between the overall number of se
detected in the NP1 and NP2 (p=0.275) (Table 2). The NP3
group consisted of 6 patients, only 2 of which had detectable se,
suggesting that some patients can develop the most severe stage of
the disease in the absence of a single exotoxin gene.
There were significantly more bacteria found in CRSwNP
patients when compared to both controls (p,0.0001) and
CRSsNP (p=0.016) patients. CRS patients had significantly more
bacteria than controls (p=0.013). There was no statistically
Enterotoxins in Rhinosinusitis
PLoS ONE | www.plosone.org 3 March 2010 | Volume 5 | Issue 3 | e9525Figure 1. Genotyping tree. MLVA genotyping of isolates recovered from patients suffering chronic rhinosinusitis from five different geographic
locations (B. Brugg; Z. Zagreb; P. Paris; L. London; G. Geneva).Control isolates (CTL) from Geneva patients arealso depicted (a single isolate perpatient is
shown). Categories areindicatedbetween brackets. Scale displays the relations betweenisolates.Isolates with a maximal distance 0.1 [
30] areconsidered
as clonal. CRSsNP=Chronic Rhinosinusitis without Nasal Polyposis group; NP1-2-3=Nasal Polyposis grade 1-2-3 groups; Ctl=control group.
doi:10.1371/journal.pone.0009525.g001
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NP1 with NP2 patients (p=0.258).
Discussion
Five main observations were obtained from this study. Firstly,
we did not find significant differences between CRSwNP,
CRSsNP and control groups regarding the number of patients
carrying intranasal SA or not.
Secondly, we did not find significant differences between
CRSwNP, CRSsNP and control groups regarding the number
of patients who had at least one se detected. Thirdly, there was no
difference between these groups in the overall quantities of se
detected. Fourthly, sep and seq were detected in 16% (9/55)
(p=0.039) and 14.5% (8/55) (p=0.033) respectively of CRSwNP
patients, but never in controls. It is, however, difficult to draw
conclusions from this finding, since these two se were only present
in a small minority of symptomatic patients and no study is yet
available regarding their biological properties in airways. Finally,
the frequency of all other individual se was similar between groups,
suggesting that the correlation between the presence of any
particular se and the severity of CRS remains unclear. In other
words, no single exotoxin gene or cluster was found to be
associated with CRS, with or without NP.
When analysing individual se, the egc constituted the most
frequently identified group of genes encoding for SE, which is in
accordance with a recent study [33]. Two isolates were carrying an
incomplete egc, lacking the seg, an event which has been described
previously [15]. The egc was equally distributed across all SA
carriers groups: thus, no correlation could be found between the
presence of the egc-gene cluster and clinical findings. This was also
the case for sea, seb, sec, sed and tsst-1. There were 9 CRSwNP
patients in whom no se was detected. These findings suggest that se
are not essential to the development of CRSwNP and actually, are
not even more common in CRSwNP than in controls that carry
SA. This may contradict previous studies which claimed that SE
were likely to be involved in the pathogenesis of CRSwNP
[2,5,6,8,21]. As previously reported, SE may change the balance
of inflammatory mediators to worsen inflammation at a histolog-
ical level [18,34], but our data suggest there is no evidence to link
this to a clinical change. Along similar lines, there was no
significant difference in the overall quantity of se detected in NP1
and NP2 patients groups. Assessment of the role of se in the NP3
group remains limited by its small number of patients. It should be
noted that out of the 9 CRSwNP patients where no se was
detected, 1 patient was in NP1, 4 were in NP2 and 4 were NP3
subgroups.
Figure 2. Rates of patients carrying S. aureus. Percentage, per
group of patients, of S. aureus with (se +) or without (se 2) exotoxin
gene.
doi:10.1371/journal.pone.0009525.g002
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PLoS ONE | www.plosone.org 5 March 2010 | Volume 5 | Issue 3 | e9525We tested for the largest number of individual exotoxins and
our se prevalence rate was the highest, at 85%. Some studies have
found that exotoxins changed the balance of inflammatory
mediators to worsen inflammation [18,34]. While this may be
indeed the case, our data suggests that the degree of histological
changes is not associated with NP1 and NP2, following endoscopic
observations. A significant correlation was found linking the
presence of sep and seq exclusively to the CRSwNP group:. Since
these two se have not yet been described in recent studies on CRS,
they would deserve further investigations. In the present study, 7/
55 CRSwNP patients had SA carrying sep and seq simultaneously.
This probably reflected two distinct genetic transfers in a single
bacterium, although they are not known to form a cluster. While
recent studies suggest a role for sep [34] and seq [35] in food
poisoning, there is no publication yet on their potential role in
CRS. Two isolates were carrying an incomplete egc, lacking the seg,
as it has been already described [15].
There was no significant difference in the quantity of all se
detected in NP1 and NP2 patients groups. Assessment of the role
of se in the NP3 group remains however limited by the small
number of patients included in this group. It should be noted that
out of the 9 CRSwNP patients where no se could be detected, 1, 4
and 4 were observed in NP1, NP2 and NP3, respectively.
Altogether, these observations suggest that the role of se in the
pathogenesis and severity of CRS remains to be clarified.
Among the 3 patients with Widal syndrome in the NP3 group, 2
had no detectable se, suggesting that this pathological entity is not
strictly dependent on the presence of se. This syndrome is
associated with a defined genetic background; the development
of CRS with or without NP in general could also include different
genetic susceptibility to the very same SA and their exotoxins, as
well as to other unknown pathological pathways.
Recent evidence has suggested that inflammatory processes in CRS
could be related to the host immune response to bacterial components
present in the nasal mucosa [3,33]. The presence of activated T
lymphocytes, within the nasal mucosa of patients with CRSwNP, and
IgE directed against SE has been suggested as evidence for a role for
exotoxins in the pathogenesis of this disease. Intranasal bacteria, with
or without exotoxins, could have various effects in different individuals,
depending on genetics and other factors within the host response.
Figure 3. Identified exotoxins. Number of different staphylococcal exotoxins identified in the CRSwNP, CRSsNP and control groups, in percentage
per groups’ population, in order to compare the three groups equally.
doi:10.1371/journal.pone.0009525.g003
Table 2. Correlations between groups.
p-value CRSwNP/CRS 0.259
p-value CRSwNP/Ctl 0.532
p-value CRS/Ctl 0.492
p-value NP3/NP2 0.036
p-value NP3/NP1 0.009
p-value NP2/NP1 0.275
Calculations made considering the total amount of exotoxin genes detected in
each group (statistical analysis: Mann Whitney U Test): the p-value is relevant for
NP1 and NP2, against NP3.
doi:10.1371/journal.pone.0009525.t002
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PLoS ONE | www.plosone.org 6 March 2010 | Volume 5 | Issue 3 | e9525To our knowledge, the present study is the largest of its type to
report on the correlation of SA exotoxin genes in CRS with and
without NP. Compared to other similar studies, it tested the largest
number of patients for the greatest number of individual se. This
may have contributed to the fact that our se prevalence rate in SA
carriers was the highest reported, at 85%. Interestingly, only 71 of
214 patients suffering from CRS were carrying SA and only 61
had se present in the SA strains. It is reasonable to expect that
fewer still would go on to have se translated into exotoxins proteins
and secreted into the extracellular compartment, where they could
become pathogenic.
Recent findings also suggest that CRS could be related to the
host genetic background and immune response to bacterial
components present in the nasal mucosa [3,33]. Intranasal
bacteria, with or without exotoxins could have various effects in
different individuals, depending on the host response.
MLVA analysis suggested that neither the geographical origin
nor the genetic background of SA isolates was associated with a
specific population. A greater number of bacteria was found in
CRSwNP when compared to CRS, as well as in CRS when
compared to controls. There was no statistical difference in the
number of bacteria present in NP1 and NP2 patients. The
presence of SA and, hence, its exotoxins in the diseased population
might be circumstantial. Indeed, mucosal inflammation of any
origin is known to be associated with mucociliary dysfunction,
which may lead to bacterial colonisation due to decreased
bacterial clearance [36–38].
The present study detected SA genes that encode exotoxins, but
not the exotoxins themselves. It is well known that the sensitivity
issue is of paramount importance for providing reliable detection
of enterotoxins at the protein level and that currently available
techniques are neither sensitive enough, nor can they detect all
known S. aureus exotoxins. Furthermore, it would be difficult to
correlate in vitro testing with in vivo conditions, which most likely
involve multiple environmental factors that affect enterotoxin gene
regulation. By identifying exotoxin genes, we aimed at exploring
which individual exotoxins were present in the different patient
groups as well as determining their frequency, making the
assumption that a preserved gene is most likely expressed. Under
specific conditions allowing gene expression, the amount of
secreted exotoxin is dependent on the number of bacteria present
in tissue. According to previously published studies, the presence
of SA may be underestimated due to the intracellular location of
bacteria [39], the presence of biofilm or that of mucus [40,41]. In
this study, we used conventional techniques to grow SA and such
methods may not be optimally sensitive to detect the presence of
specific bacterial modes of growth, like intracellular growth or
biofilms. Thus, culture positivity may vary over time due to such
technical challenges [39]. In this study, there was no statistical
difference in the number of bacteria present in NP1 and NP2
patients. A greater quantity of bacteria may be a consequence,
rather than a cause of the inflammation, or may be both. Thus, the
possible contribution of SA exotoxins in the pathogenesis of CRS
remains to be clarified since only 71/214 patients suffering from
this disease were carrying SA.
To date, studies suggesting a role of SA exotoxins in CRS, as
well as in other diseases, are based on gene detection. As recently
illustrated by Katsuhiko Omoe et al., « most of the S. aureus isolates
harboring seg and about 60% of the isolates harboring sei did not
produce a detectable level of SEG or SEI » [42]. This was also
recently illustrated by Young-Duck and colleagues [43] who
reported a good correlation between gene presence and gene
expression, but a poor correlation between gene expression or
presence and protein presence. The possible role of superantigens
in the development of CRS is supported by the presence of
activated Tvb lymphocytes as well as IgE in the nasal mucosa of
patients with NP. However, their role in the constitution of NP has
not yet been clarified. Taken together, this suggests that we may
overestimate the prevalence of secreted exotoxins as well as that of
their pathogenic role.
In summary, we did not find any correlation between the
presence of Staphylococcus aureus and the development of CRS,
with or without polyps. Our study focused on exotoxin genes of SA
carriers: we did neither find any correlation between the presence
of any particular se, nor large numbers of se, and CRS, with or
without NP. In addition, there was no evidence that se may
influence the severity of the disease and development of nasal
polyposis. Nevertheless, the genes for recently discovered entero-
toxins P and Q were detected for the first time in CRS and
CRSwNP: further research may provide new insights into their
role. It has been suggested that theoretically, an infinite number of
SE may arise from complex immune processes which stimulate
genetic mutations in SA [11]. New exotoxins may remain to be
discovered.
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